← Back to headlines
Analyst Bullish on Beam Therapeutics Over Drug Program Trajectory
An analyst expresses a bullish sentiment on Beam Therapeutics (BEAM) due to the promising trajectory of its drug programs.
19 Feb, 00:39 — 19 Feb, 00:39
ℹOnly 1 source covers this story
